LINC01826: A Non-Coding RNA Molecule and Its Potential Applications

Target Name: LINC01826

NCBI ID: G107985818

LINC01826

Other Name(s): Long intergenic non-protein coding RNA 1826 | lnc-MKI67IP-3 | long intergenic non-protein coding RNA 1826

LINC01826: A Non-Coding RNA Molecule and Its Potential Applications

LINC01826 is a non-coding RNA (ncRNA) molecule that has been identified using RNA-seq technology as having different levels of expression in various tissues and organs in the mouse body. The gene that encodes LINC01826 has a length of 291 amino acids and is located on chromosome 6p12.3.

The function of LINC01826 is not well understood, but it is known to play a role in the regulation of gene expression. LINC01826 is expressed in various tissues and organs and has been shown to be involved in the regulation of stem cell proliferation, differentiation and immune response.

One of the promising aspects of LINC01826 is its potential as a drug target or biomarker. LINC01826 has been shown to be involved in the regulation of immune cell function and has been linked to the development of various diseases, including cancer. Therefore, targeting LINC01826 with small molecules or other therapeutic agents may be a promising strategy for the development of new treatments for these diseases.

Another potential application of LINC01826 is its use as a biomarker for monitoring disease progression. The regulation of LINC01826 expression has been observed to be associated with various diseases, including cancer, autoimmune diseases and neurodegenerative diseases. By measuring the levels of LINC01826 in biological samples, such as serum, plasma, or tissue, it may be possible to monitor the effectiveness of new treatments and determine the impact of disease progression on LINC01826 expression.

LINC01826 has also been shown to play a role in the regulation of stem cell proliferation and differentiation. Stem cells are a crucial cell type that have the ability to generate various tissues and organs in the body. The regulation of stem cell proliferation and differentiation is critical for the development and maintenance of these cells, and LINC01826 is thought to be involved in this process.

In conclusion, LINC01826 is a non-coding RNA molecule that has been identified as having different levels of expression in various tissues and organs in the mouse body. Its function is not well understood, but it is known to play a role in the regulation of gene expression and has been linked to the development of various diseases. As a potential drug target or biomarker, LINC01826 is a promising target for the development of new treatments for these diseases. Additionally, its role in the regulation of stem cell proliferation and differentiation also suggests its potential as a therapeutic agent for the treatment of various diseases. Further research is needed to fully understand the function of LINC01826 and its potential as a drug target or biomarker.

Protein Name: Long Intergenic Non-protein Coding RNA 1826

The "LINC01826 Target / Biomarker Review Report" is a customizable review of hundreds up to thousends of related scientific research literature by AI technology, covering specific information about LINC01826 comprehensively, including but not limited to:
•   general information;
•   protein structure and compound binding;
•   protein biological mechanisms;
•   its importance;
•   the target screening and validation;
•   expression level;
•   disease relevance;
•   drug resistance;
•   related combination drugs;
•   pharmacochemistry experiments;
•   related patent analysis;
•   advantages and risks of development, etc.
The report is helpful for project application, drug molecule design, research progress updates, publication of research papers, patent applications, etc. If you are interested to get a full version of this report, please feel free to contact us at BD@silexon.ai

More Common Targets